Bausch Health Announces First Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Bausch Health Companies (BHC) PT Lowered to $10 at RBC Capital
May 3, 2024 6:36 AM EDTRBC Capital analyst Doug Miehm lowered the price target on Bausch Health Companies (NYSE: BHC) to $10.00 (from $11.00) while maintaining a Sector Perform rating.
The analyst comments "Between Q1 EBITDA that was weaker than expected and little incremental visibility on the BLCO separation... More
